Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19 Publisher Pubmed



Rezaei M1, 2 ; Marjani M2 ; Mahmoudi S3 ; Mortaz E2 ; Mansouri D2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: International Archives of Allergy and Immunology Published:2021


Abstract

Background: Although the pathophysiology of coronavirus disease 2019 (COVID-19) is not clearly defined, among the proposed mechanisms, immune system dysfunction is more likely than others. The aim of this study was to clarify the characteristics and clinical significance of dynamic changes of lymphocyte subsets in the course of COVID-19. Methods: In this prospective study, the levels of peripheral lymphocyte subsets including CD4+, CD8+, CD4+CD25+FOXP3+, CD38+, CD3+HLA-DR+, CD19+, CD20+, and CD16+CD56+ cells were measured by flow cytometry in 52 confirmed hospitalized patients with COVID-19 at the day of admission and after 7 days of care. Clinical response was defined as improvement in symptoms (fever, dyspnea, and cough as well as blood oxygen saturation), and patients who met these criteria after 1 week of admission were classified as early responders; others who survived and finally discharged from the hospital were classified as late responders and patients who died were categorized as nonresponders. Immunophenotyping of studied cell changes on the first day of admission and 7 days after treatment were compared. Besides, the correlation between cellular subset variation and clinical response and outcome were analyzed. Results: Total counts of white blood cell, T cells, CD4+ T cells, CD8+ T cells, CD38+ lymphocytes, and CD3+HLA-DR+ lymphocytes were significantly increased in both early and late responders. No statistically significant difference was observed in CD4+/CD8+ ratio, B cells, FOXP3+Treg lymphocytes, and FOXP3 median fluorescence intensity among studied groups. According to the multivariate analysis, an increase in CD4+ T cells (p = 0.019), CD8+ T cells (p = 0.001), and administration of interferon (p < 0.001) were independent predictors of clinical response. Conclusion: We found an increasing trend in total T cells, T helpers, cytotoxic T cells, activated lymphocytes, and natural killer cells among responders. This trend was not statistically significant among nonresponders. The findings of this study may enhance our knowledge about the pathogenesis of COVID-19. © 2021 S. Karger AG. All rights reserved.
Other Related Docs
15. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
16. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
28. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)
30. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
36. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
38. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
42. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
43. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
44. Covid-19 Infection in Children With Underlying Malignancies in Iran, Journal of Basic and Clinical Physiology and Pharmacology (2022)
48. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)